Last reviewed · How we verify
NCT05547204
Impact of Coffeeberry Extract on Skill Performance During Simulated Match Play in Academy Football Players
NA trial testing Beverage in Skill Performance in 15 participants. Completed in 4 December 2022.
4 December 2022
Quick facts
| Lead sponsor | PepsiCo Global R&D |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | quadruple |
| Primary purpose | basic science |
| Enrollment | 15 |
| Start date | 30 June 2022 |
| Primary completion | 4 December 2022 |
| Estimated completion | 4 December 2022 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Beverage
Conditions studied
- Skill Performance — all drugs for Skill Performance →
- Soccer Performance — all drugs for Soccer Performance →
- Coffeeberry Effects — all drugs for Coffeeberry Effects →
Sponsor
PepsiCo Global R&D — full company profile →
Who can join
Adults 16 to 28, any sex, with Skill Performance or Soccer Performance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study of soccer skill performance has three objectives: 1. Compare effects of coffeeberry (300mg) and placebo ingestion on dribbling speed and precision, passing speed and accuracy, and sprint speed during a full simulated soccer match. 2. Compare effects of coffeeberry (300mg) and placebo ingestion on subjective measures (mental / physical energy and activation-deactivation (feelings or mood) during a full simulated soccer match. 3. Compare effects of coffeeberry (300mg) and placebo ingestion on chlorogenic acid (CGA) and caffeine metabolites in the blood 1-hour post ingestion, and other blood metabolites (glucose/lactate) throughout the simulated soccer match.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05547204
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Beverage
Trials testing the same drug.
- NCT06933290 — Effect of Flavored, Carbonated Drinks on Salivary Flow, Salivary Composition, and Taste Perceptions · NA · recruiting
- NCT04331288 — Effects of Ethanol on the Pharmacokinetics of PT-150 (Formerly ORG34517) (PT150 PK Study) · Phase 1 · completed
- NCT04281758 — Comparison of Plasma Caffeine Concentration After Oral Consumption of Caffeinated Beverages With Varied Bioactive Compou · Phase 1 · completed
- NCT03548714 — Clinical Trial to Evaluate the Safety of PT150 (Formerly ORG34517) When it is Taken Concurrently With Alcohol · Phase 1 · completed
Other recruiting trials for Skill Performance
Currently open trials in the same condition.
- NCT07358741 — Standard Two-Day Advanced Life Support (ALS) Versus One Day Recertification Course · recruiting
Other PepsiCo Global R&D trials
Trials by the same sponsor.
- NCT07429201 — Comparing an Electrolyte-Carbohydrate Beverage to Water During Ramadan · NA · completed
- NCT07400614 — Evaluating the Impact of Energy Drink Formulas on Alertness for an Extended Period · NA · recruiting
- NCT07427654 — Determination of the Glycemic Index of Products Varying in Levels of Refined and Whole Grain Corn · NA · completed
- NCT07298863 — The Effect of Hydration Status on Substrate Oxidation at Rest and During Light and Moderate Exercise · NA · recruiting
- NCT07217834 — Effects of a Glycerol-Electrolyte Beverage on Fluid Balance in Healthy Euhydrated Men and Women · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05547204 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by PepsiCo Global R&D
- Last refreshed: 16 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05547204.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing